Buprenorphine, an FDA-approved medication for opioid use disorder, reduces withdrawal and cravings for fentanyl. What’s more, it decreases overdose risk by more than 50%. Finally, the ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation. A new report from the Centers for Disease Control ...

The deal resolves criminal and civil liabilities faced by the company related to charges it engaged in an illicit nationwide scheme to increase prescriptions of opioid addiction drug Suboxone Film ...

The Emergency Department-initiated Medications to Treat Opioid Use Disorder (ED-MOUD) program will allow people suffering with Opioid Use Disorder to be prescribed buprenorphine (also known as ...

Check the currency rates against all the world currencies here. The currency converter below is easy to use and the currency rates are updated frequently. This is very much needed given the ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Objectives were to provide dose-increment justification for conversion of a patient from conventional enteric-coated divalproex to a once-daily divalproex ER regimen and to discuss the ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

The UK's Top 100 biggest artist albums of the week, compiled by the Official Charts Company based on sales of CDs, downloads, vinyl, audio streams and video streams. View the biggest albums of 2024.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...